Cancer Research, 02/21/2013
(APPARANTLY THIS IS NOT FOUND NATURALLY IN NORMAL BLOOD)
2Multicentre phase II trial of bevacizumab combined with docetaxel carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905) | ||||||||||||||||||||||||||
Annals of Oncology 02/06/2013 | STUDY COMPLETED IN KOREA |
No comments:
Post a Comment